JAMES GALE

Profile

First Name

: JAMES

Middle Name

:

Last Name

: GALE

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-22 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-08-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-01 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-03 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2014-07-03 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2012-12-21 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
 
2010-12-21 
D
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2010-12-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-01